"Double-edged Sword" Effect of Reactive Oxygen Species (ROS) in Tumor Development and Carcinogenesis

Overview

Journal Physiol Res

Specialty Physiology

Date 2023 Jul 14

PMID 37449744

Authors

W Zhao

P Zhuang

Y Chen

Y Wu

M Zhong

Y Lun

Affiliations

Soon will be listed here.

Abstract

Reactive oxygen species (ROS) are small reactive molecules produced by cellular metabolism and regulate various physiological and pathological functions. Many studies have shown that ROS plays an essential role in the proliferation and inhibition of tumor cells. Different concentrations of ROS can have a "double-edged sword" effect on the occurrence and development of tumors. A certain concentration of ROS can activate growth-promoting signals, enhance the proliferation and invasion of tumor cells, and cause damage to biomacromolecules such as proteins and nucleic acids. However, ROS can enhance the body's antitumor signal at higher levels by initiating oxidative stress-induced apoptosis and autophagy in tumor cells. This review analyzes ROS's unique bidirectional regulation mechanism on tumor cells, focusing on the key signaling pathways and regulatory factors that ROS affect the occurrence and development of tumors and providing ideas for an in-depth understanding of the mechanism of ROS action and its clinical application.

Citing Articles

Diquat Induces Cell Death and dopamine Neuron Loss via Reactive Oxygen Species Generation in .

Wang B, Yin Z, Liu J, Tang C, Zhang Y, Wang L Environ Sci Technol. 2025; 59(1):152-162.

PMID: 39745087 PMC: 11740995. DOI: 10.1021/acs.est.4c07783.

Single-cell transcriptomics reveals over-activated reactive oxygen species pathway in hepatocytes in the development of hepatocellular carcinoma.

Wang X, Li P, Ji H, Xu Z, Xing H Sci Rep. 2024; 14(1):29809.

PMID: 39616235 PMC: 11608336. DOI: 10.1038/s41598-024-81481-0.

Mitochondrial Dysfunction in Systemic Lupus Erythematosus: Insights and Therapeutic Potential.

Poznyak A, Orekhov N, Churov A, Starodubtseva I, Beloyartsev D, Kovyanova T Diseases. 2024; 12(9).

PMID: 39329895 PMC: 11430897. DOI: 10.3390/diseases12090226.

Activity of NAD(P)H-Oxidoreductases in Ovarian Cancer.

Fedorova M, Voznesensky V, Sosnova E, Proskurnina E Biomedicines. 2024; 12(5).

PMID: 38791014 PMC: 11117946. DOI: 10.3390/biomedicines12051052.

Circ_005077 accelerates myocardial lipotoxicity induced by high-fat diet via CyPA/p47PHOX mediated ferroptosis.

Ni X, Duan L, Bao Y, Li J, Zhang X, Jia D Cardiovasc Diabetol. 2024; 23(1):129.

PMID: 38622592 PMC: 11020354. DOI: 10.1186/s12933-024-02204-3.

References

Duan C, Zhang B, Deng C, Cao Y, Zhou F, Wu L . Piperlongumine induces gastric cancer cell apoptosis and G2/M cell cycle arrest both in vitro and in vivo. Tumour Biol. 2016; 37(8):10793-804. DOI: 10.1007/s13277-016-4792-9. View

Moloney J, Cotter T . ROS signalling in the biology of cancer. Semin Cell Dev Biol. 2017; 80:50-64. DOI: 10.1016/j.semcdb.2017.05.023. View

Chen Y, Xie X, Zhou C, Xu C . [Methotrexate-induced apoptosis of JAR cells of choriocarcinoma and expression of its related proteins]. Zhonghua Fu Chan Ke Za Zhi. 2004; 39(8):558-9. View

Binder S, Hosikova B, Mala Z, Zarska L, Kolarova H . Effect of ClAlPcS(2) photodynamic and sonodynamic therapy on HeLa cells. Physiol Res. 2020; 68(Suppl 4):S467-S474. DOI: 10.33549/physiolres.934374. View

Zhou X, Chen J, Yi G, Deng M, Liu H, Liang M . Metformin suppresses hypoxia-induced stabilization of HIF-1α through reprogramming of oxygen metabolism in hepatocellular carcinoma. Oncotarget. 2015; 7(1):873-84. PMC: 4808039. DOI: 10.18632/oncotarget.6418. View

Tobar N, Villar V, Santibanez J . ROS-NFkappaB mediates TGF-beta1-induced expression of urokinase-type plasminogen activator, matrix metalloproteinase-9 and cell invasion. Mol Cell Biochem. 2010; 340(1-2):195-202. DOI: 10.1007/s11010-010-0418-5. View

Yang H, Villani R, Wang H, Simpson M, Roberts M, Tang M . The role of cellular reactive oxygen species in cancer chemotherapy. J Exp Clin Cancer Res. 2018; 37(1):266. PMC: 6211502. DOI: 10.1186/s13046-018-0909-x. View

Han X, Sun S, Zhao M, Cheng X, Chen G, Lin S . Celastrol stimulates hypoxia-inducible factor-1 activity in tumor cells by initiating the ROS/Akt/p70S6K signaling pathway and enhancing hypoxia-inducible factor-1α protein synthesis. PLoS One. 2014; 9(11):e112470. PMC: 4226555. DOI: 10.1371/journal.pone.0112470. View

Garg M, Kanojia D, Mayakonda A, Ganesan T, Sadhanandhan B, Suresh S . Selinexor (KPT-330) has antitumor activity against anaplastic thyroid carcinoma in vitro and in vivo and enhances sensitivity to doxorubicin. Sci Rep. 2017; 7(1):9749. PMC: 5575339. DOI: 10.1038/s41598-017-10325-x. View

10.

Megias-Vericat J, Montesinos P, Herrero M, Moscardo F, Boso V, Rojas L . Impact of NADPH oxidase functional polymorphisms in acute myeloid leukemia induction chemotherapy. Pharmacogenomics J. 2017; 18(2):301-307. DOI: 10.1038/tpj.2017.19. View

11.

Brentnall M, Rodriguez-Menocal L, De Guevara R, Cepero E, Boise L . Caspase-9, caspase-3 and caspase-7 have distinct roles during intrinsic apoptosis. BMC Cell Biol. 2013; 14:32. PMC: 3710246. DOI: 10.1186/1471-2121-14-32. View

12.

Kasiappan R, Jutooru I, Karki K, Hedrick E, Safe S . Benzyl Isothiocyanate (BITC) Induces Reactive Oxygen Species-dependent Repression of STAT3 Protein by Down-regulation of Specificity Proteins in Pancreatic Cancer. J Biol Chem. 2016; 291(53):27122-27133. PMC: 5207142. DOI: 10.1074/jbc.M116.746339. View

13.

Taguchi K, Fujikawa N, Komatsu M, Ishii T, Unno M, Akaike T . Keap1 degradation by autophagy for the maintenance of redox homeostasis. Proc Natl Acad Sci U S A. 2012; 109(34):13561-6. PMC: 3427110. DOI: 10.1073/pnas.1121572109. View

14.

Qi S, Xin Y, Guo Y, Diao Y, Kou X, Luo L . Ampelopsin reduces endotoxic inflammation via repressing ROS-mediated activation of PI3K/Akt/NF-κB signaling pathways. Int Immunopharmacol. 2011; 12(1):278-87. DOI: 10.1016/j.intimp.2011.12.001. View

15.

Sies H, Jones D . Reactive oxygen species (ROS) as pleiotropic physiological signalling agents. Nat Rev Mol Cell Biol. 2020; 21(7):363-383. DOI: 10.1038/s41580-020-0230-3. View

16.

Waters M, Stack H . The short-term test activity profile for procarbazine hydrochloride. Mutagenesis. 1988; 3(2):89-94. DOI: 10.1093/mutage/3.2.89. View

17.

Glory A, Bettaieb A, Averill-Bates D . Mild thermotolerance induced at 40 °C protects cells against hyperthermia-induced pro-apoptotic changes in Bcl-2 family proteins. Int J Hyperthermia. 2014; 30(7):502-12. DOI: 10.3109/02656736.2014.968641. View

18.

Nassereddine S, Lap C, Tabbara I . Evaluating ivosidenib for the treatment of relapsed/refractory AML: design, development, and place in therapy. Onco Targets Ther. 2019; 12:303-308. PMC: 6314316. DOI: 10.2147/OTT.S182443. View

19.

Gao X, Schottker B . Reduction-oxidation pathways involved in cancer development: a systematic review of literature reviews. Oncotarget. 2017; 8(31):51888-51906. PMC: 5584299. DOI: 10.18632/oncotarget.17128. View

20.

Goldmann E . The Growth of Malignant Disease in Man and the Lower Animals, with special reference to the Vascular System. Proc R Soc Med. 2009; 1(Surg Sect):1-13. PMC: 2045808. View